Which of the following statements about cryptococcal meningitis is incorrect?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 30, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

The INCORRECT Statement is E: Diagnosis is NOT established via brain MRI

Cryptococcal meningitis is diagnosed through cerebrospinal fluid (CSF) analysis—not brain MRI—using India ink staining, cryptococcal antigen testing, and fungal culture. 1

Why Each Statement is Correct or Incorrect:

A) Most common cause of fungal meningitis - CORRECT

Cryptococcal meningitis accounts for approximately 90% of fungal meningitis cases 2. This is well-established across multiple sources and represents the predominant fungal CNS infection globally.

B) Risk factors include HIV infection - CORRECT

HIV infection with CD4 counts <100 cells/μL is the most significant risk factor 1. The IDSA guidelines specifically address HIV-associated cryptococcal meningitis as a major category, with recommendations for HAART initiation 2-10 weeks after starting antifungal therapy 1.

C) First-line treatment is liposomal amphotericin B - CORRECT

The IDSA guidelines establish that liposomal amphotericin B (3-4 mg/kg/day) plus flucytosine for at least 2 weeks is first-line induction therapy 1. While amphotericin B deoxycholate (0.7-1.0 mg/kg/day) plus flucytosine is also listed as first-line (A-I evidence), liposomal formulations are preferred in patients with or predisposed to renal dysfunction (B-II evidence) 1. In transplant recipients specifically, liposomal amphotericin B is the primary recommendation 1.

D) Frequently causes elevated intracranial pressure - CORRECT

Elevated intracranial pressure is a well-recognized and common complication requiring aggressive management with daily therapeutic lumbar punctures until normalization 1, 3. The guidelines emphasize that adequate measures to manage increased intracranial pressure are critical for successful outcomes 1.

E) Diagnosis established via brain MRI - INCORRECT

Brain MRI is NOT the diagnostic modality for cryptococcal meningitis. Diagnosis requires:

  • CSF analysis with:

    • India ink staining (visualizes encapsulated yeast) 4, 5
    • Cryptococcal antigen (CrAg) testing in CSF and serum 3, 4
    • Fungal culture (gold standard) 4, 5
    • PCR for Cryptococcus species 5, 6
  • Brain MRI findings (leptomeningeal enhancement, cryptococcomas, hydrocephalus) are supportive but not diagnostic 2, 4, 5, 7. Multiple case reports demonstrate that imaging abnormalities can be nonspecific or even misleading, with initial imaging sometimes suggesting alternative diagnoses like stroke 7.

Critical Diagnostic Pitfall:

Serial CSF sampling may be necessary if initial testing is negative but clinical suspicion remains high 5. One case report documented a false-negative initial CSF analysis in an immunocompetent patient, with confirmation only on repeat testing 5. In tuberculosis-endemic regions, cryptococcal meningitis is frequently misdiagnosed as tuberculous meningitis due to overlapping CSF findings (lymphocytic pleocytosis, low glucose, elevated protein) 4.

Related Questions

Given a patient with a typical presentation requiring amphotericin‑flucytosine induction, what is the most likely diagnosis?
What is the recommended treatment for oral Cryptococcus lesions?
What are the side effects of flucytosine and amphotericin B when used to treat a central nervous system fungal infection such as a dural abscess?
What is the management for an asymptomatic neurological patient with a positive Cryptococcal Antigen in blood?
In a critically ill adult with prolonged fever, weight loss, seizures, leptomeningeal enhancement on MRI, normal CSF glucose, mildly elevated protein, low CSF cell count, negative cryptococcal and leptospira tests, and worsening leukocytosis while on broad‑spectrum antibiotics, antivirals, antifungals, dexamethasone, and mannitol, should anti‑tubercular therapy be started and what is the recommended drug regimen and adjunctive treatment?
In a 79‑kg adult with type‑2 diabetes on metformin and ozempic who presents with right‑upper‑quadrant pain, yellow urine and stool, markedly elevated transaminases (AST ≈1400 U/L, ALT ≈2100 U/L) and cholestatic enzymes (ALP ≈700 U/L, GGT ≈900 U/L) with elevated bilirubin, and a positive hepatitis A RNA PCR, are these findings solely attributable to acute hepatitis A infection, or could autoimmune hepatitis also be present?
How long must a patient abstain from alcohol before starting oral naltrexone?
For a woman with recurrent urinary tract infections, should Bactrim (trimethoprim‑sulfamethoxazole) be prescribed for three days or five days?
Can the combination of lamotrigine and olanzapine be effective for treating obsessive‑compulsive disorder after first‑line therapies have failed?
How many hours before a left‑heart catheterization should therapeutic enoxaparin (Lovenox) 65 mg be held?
How can I simplify the medication regimen of a patient taking clonazepam (Klonopin) 1 mg twice daily, aripiprazole (Abilify) 10 mg once daily, lisdexamfetamine (Vyvanse) 30 mg daily, vilazodone (Viibryd) 40 mg once daily, and dextromethorphan‑bupropion (Auvelity) 45‑105 mg twice daily?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.